Franklin Resources Inc Aerie Pharmaceuticals Inc Transaction History

Franklin Resources Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 10, 2021	SELL	$9.12 - $14.49 $11 Million - $17.5 Million	-1,210,766 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$10.46 - $14.46 $386,664 - $534,528	36,966 Added 3.15%	1,210,766 $14.3 Million
Q1 2020 May 13, 2020	BUY	$11.84 - $25.52 $361,120 - $778,360	30,500 Added 2.67%	1,173,800 $15.8 Million
Q4 2019 Feb 12, 2020	BUY	$17.72 - $25.1 $20.3 Million - $28.7 Million	1,143,300 New	1,143,300 $27.6 Million

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.